Larson Financial Group’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.5K Buy
890
+878
+7,317% +$15.2K ﹤0.01% 2308
2026
Q2
$216 Buy
+12
New +$168 ﹤0.01% 3596
2025
Q2
– Sell
-628
Closed -$13.8K – 3387
2025
Q1
$13.8K Hold
628
– – ﹤0.01% 1512
2024
Q4
$14.2K Buy
628
+6
+1% +$131 ﹤0.01% 1348
2024
Q3
$11.3K Buy
+622
New +$14.4K ﹤0.01% 1434
2023
Q2
– Sell
-100
Closed -$5.74K – 1601
2023
Q1
$5.74K Hold
100
– – ﹤0.01% 1059
2022
Q4
$5.61K Hold
100
– – ﹤0.01% 1001
2022
Q3
$4K Buy
+100
New +$5.12K ﹤0.01% 994

Other funds holding IART

Larson Financial Group's IART Position: Q3 2026 in Review

Larson Financial Group increased its Integra LifeSciences (IART) stake by 7,317% in Q3 2026, buying an estimated $15.2K and bringing the position to 890 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2308.

Larson Financial Group first reported a position in IART in Q3 2022 and has held it in 8 quarters since. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Larson Financial Group held 890 shares of Integra LifeSciences worth $14.5K as of Q3 2026.
  • Larson Financial Group bought 878 Integra LifeSciences shares in Q3 2026, an estimated $15.2K.
  • Integra LifeSciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2308 holding.
  • Larson Financial Group first reported a position in Integra LifeSciences in Q3 2022 and has held it in 8 quarters since.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.